tpoxx- tecovirimat monohydrate injection, solution, concentrate tpoxx- tecovirimat monohydrate capsule
siga technologies, inc. - tecovirimat (unii: f925rr824r) (tecovirimat - unii:f925rr824r) - tpoxx® is indicated for the treatment of human smallpox disease caused by variola virus in adults and pediatric patients weighing at least 3 kg. the effectiveness of tpoxx for treatment of smallpox disease has not been determined in humans because adequate and well-controlled field trials have not been feasible, and inducing smallpox disease in humans to study the drug’s efficacy is not ethical [see clinical studies (14)] . tpoxx efficacy may be reduced in immunocompromised patients based on studies demonstrating reduced efficacy in immunocompromised animal models. tpoxx capsules: none. tpoxx injection: the excipient hydroxypropyl-β-cyclodextrin is eliminated through glomerular filtration. therefore, tpoxx injection is contraindicated in patients with severe renal impairment (defined as creatinine clearance below 30 ml/min) [see warnings and precautions (5.2) and use in specific populations (8.6)] . risk summary there are no available data on the use of tecovirimat in pregnant individuals to evaluate for a
dexemel 4% 40 mg/ml solvent for parenteral use
innovata plc - icodextrin sodium chloride ph.eur. s(+) sodium lactate 960%w/w solution calcium chloride dihydrate magnesium chloride hexahydrate - solvent for parenteral use - 40 mg/ml
extraneal peritoneal dialysis solution 75gl
baxter healthcare (malaysia) sdn. bhd. - icodextrin; calcium chloride ph eur; magnesium chloride ph eur; sodium lactate usp; sodium chloride ph eur -
voriconazol normon 200 mg pulver zur herstellung einer infusionslösung
voriconazol aramed 200 mg pulver zur herstellung einer infusionslösung
enervade
agrihealth nz limited - sodium bicarbonate; potassium chloride; sodium chloride; malto-dextrine; potassium phosphate monobasic; dextrose; dextrin; glycine; potassium citrate - sodium bicarbonate 65.71 g/kg; potassium chloride 10 g/kg; sodium chloride 88.57 g/kg; malto-dextrine 35.72 g/kg; potassium phosphate monobasic 28.43 g/kg; dextrose 571.4 g/kg; dextrin 107.18 g/kg; glycine 91.53 g/kg; potassium citrate 1.44 g/kg - oral nutrient/electrolyte
extraneal solution
baxter corporation - sodium chloride; sodium lactate; calcium chloride; magnesium chloride; icodextrin - solution - 5.35g; 4.48g; 257mg; 51mg; 75g - sodium chloride 5.35g; sodium lactate 4.48g; calcium chloride 257mg; magnesium chloride 51mg; icodextrin 75g - hemodialysis solution
voriconazole 200 mg
max health limited - voriconazole 200mg - powder for infusion - 200 mg - active: voriconazole 200mg excipient: hydrochloric acid hydroxypropyl-beta-cyclodextrin sodium chloride - voriconazole is indicated for treatment of the following fungal infections: · invasive aspergillosis. · serious candida infections (including c. krusei), including oesophageal and systemic candida infections (hepatosplenic candidiasis, disseminated candidiasis, candidaemia). · serious fungal infections caused by scedosporium spp. and fusarium spp. · other serious fungal infections, in patients intolerant of, or refractory to, other therapy.
voriconazol al 200 mg pulver zur herstellung einer infusionslösung
voriconazole hikma (previously voriconazole hospira)
hikma farmaceutica (portugal) s.a. - voriconazole - bacterial infections and mycoses; aspergillosis; candidiasis - antimycotics for systemic use - voriconazole is a broad spectrum, triazole antifungal agent and is indicated in adults and children aged 2 years and above as follows:treatment of invasive aspergillosis;treatment of candidaemia in non-neutropenic patients;treatment of fluconazole-resistant serious invasive candida infections (including c. krusei);treatment of serious fungal infections caused by scedosporium spp. and fusarium spp.voriconazole should be administered primarily to patients with progressive, possibly life-threatening infections.prophylaxis of invasive fungal infections in high risk allogeneic hematopoietic stem cell transplant (hsct)recipients.